These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 21643807)
1. Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. Kao YH; Tan EH; Ng CE; Goh SW Ann Nucl Med; 2011 Aug; 25(7):455-61. PubMed ID: 21643807 [TBL] [Abstract][Full Text] [Related]
2. A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications. Rodríguez LS; Thang SP; Li H; Khor LK; Tay YS; Myint KO; Tong AK Ann Nucl Med; 2016 Apr; 30(3):255-61. PubMed ID: 26692012 [TBL] [Abstract][Full Text] [Related]
3. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789 [TBL] [Abstract][Full Text] [Related]
4. Intrahepatic Activity Distribution in Radioembolization with Yttrium-90-Labeled Resin Microspheres Using the Body Surface Area Method--A Less than Perfect Model. Grosser OS; Ulrich G; Furth C; Pech M; Ricke J; Amthauer H; Ruf J J Vasc Interv Radiol; 2015 Nov; 26(11):1615-21. PubMed ID: 26321017 [TBL] [Abstract][Full Text] [Related]
5. Calculation of tumour and normal tissue biological effective dose in Gallio E; Richetta E; Finessi M; Stasi M; Pellerito RE; Bisi G; Ropolo R Phys Med; 2016 Dec; 32(12):1738-1744. PubMed ID: 27876284 [TBL] [Abstract][Full Text] [Related]
6. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462 [TBL] [Abstract][Full Text] [Related]
7. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. Salem R; Thurston KG J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999 [TBL] [Abstract][Full Text] [Related]
8. Radioembolization with 90Y microspheres: technical considerations. Salem R J Vasc Interv Radiol; 2007 Nov; 18(11):1460-1. PubMed ID: 18004003 [No Abstract] [Full Text] [Related]
9. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867 [TBL] [Abstract][Full Text] [Related]
10. Dosimetry and prescription in liver radioembolization with Mañeru F; Abós D; Bragado L; Fuentemilla N; Caudepón F; Pellejero S; Miquelez S; Rubio A; Goñi E; Hernández-Vitoria A Phys Med Biol; 2017 Nov; 62(23):9099-9111. PubMed ID: 29057748 [TBL] [Abstract][Full Text] [Related]
11. Validation of post-treatment PET-based dosimetry software for hepatic radioembolization of Yttrium-90 microspheres. Maughan NM; Garcia-Ramirez J; Arpidone M; Swallen A; Laforest R; Goddu SM; Parikh PJ; Zoberi JE Med Phys; 2019 May; 46(5):2394-2402. PubMed ID: 30742714 [TBL] [Abstract][Full Text] [Related]
12. Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method. Ahmadzadehfar H; Haslerud T; Reichmann K; Meyer C; Habibi E; Fimmers R; Muckle M; Sabet A; Biersack HJ; Ezziddin S Nuklearmedizin; 2014; 53(3):95-8. PubMed ID: 24105253 [TBL] [Abstract][Full Text] [Related]
13. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors. Gates VL; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Nemcek AA; Omary R; Salem R Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504 [TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres. Sarwar A; Kudla A; Weinstein JL; Ali A; Malik R; Bullock A; Khwaja KO; Curry M; Faintuch S; Ahmed M Eur Radiol; 2021 Mar; 31(3):1316-1324. PubMed ID: 32901301 [TBL] [Abstract][Full Text] [Related]
16. Impact of the activity calculation method used in transarterial radioembolization: a dosimetric comparison between 90Y-SIRSphere and 90Y-TheraSphere therapy. Jha AK; Mithun S; Purandare NC; Shah SA; Agrawal A; Kulkarni SS; Shetty N; Rangarajan V Nucl Med Commun; 2016 Sep; 37(9):917-23. PubMed ID: 27182686 [TBL] [Abstract][Full Text] [Related]
17. A guide to Kim SP; Cohalan C; Kopek N; Enger SA Phys Med; 2019 Dec; 68():132-145. PubMed ID: 31785502 [TBL] [Abstract][Full Text] [Related]
18. Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres. Van den Eynde M; Flamen P; El Nakadi I; Liberale G; Delatte P; Larsimont D; Hendlisz A Clin Nucl Med; 2008 Oct; 33(10):697-9. PubMed ID: 18806572 [No Abstract] [Full Text] [Related]
19. Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes. Kennedy AS; Kleinstreuer C; Basciano CA; Dezarn WA Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):631-7. PubMed ID: 19910131 [TBL] [Abstract][Full Text] [Related]
20. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432. Ho S; Lau WY; Leung WT Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473 [No Abstract] [Full Text] [Related] [Next] [New Search]